SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-16-000026
Filing Date
2016-09-06
Accepted
2016-09-06 17:16:18
Documents
54
Period of Report
2016-07-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT pharmacyte_10q-073116.htm 10-Q 302928
2 CERTIFICATION pharmacyte_10q-ex3101.htm EX-31.1 9021
3 CERTIFICATION pharmacyte_10q-ex3201.htm EX-32.1 5735
  Complete submission text file 0001683168-16-000026.txt   2362015

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE pmcb-20160731.xml EX-101.INS 418218
5 XBRL SCHEMA FILE pmcb-20160731.xsd EX-101.SCH 27944
6 XBRL CALCULATION FILE pmcb-20160731_cal.xml EX-101.CAL 39684
7 XBRL DEFINITION FILE pmcb-20160731_def.xml EX-101.DEF 109662
8 XBRL LABEL FILE pmcb-20160731_lab.xml EX-101.LAB 214463
9 XBRL PRESENTATION FILE pmcb-20160731_pre.xml EX-101.PRE 178069
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 161871519
SIC: 2833 Medicinal Chemicals & Botanical Products